"A cancer diagnosis can be devastating not only to the patient receiving it but to the patient’s family and loved ones. Your first concern is about where you can find the best oncology doctor and get the most advanced, most effective oncology treatment. You’ll find exceptional cancer treatments right here in Laredo, thanks to Eduardo Miranda, MD, a board-certified oncology doctor and hematology specialist. Dr. Miranda is a triple board certified specialist in medical oncology, hematology and internal medicine, highly experienced in providing comprehensive care to patients with the most common types of cancer and blood disorders. Dr. Miranda and his team treat blood disorders, including treatment for anemia, leukemia & acute leukemia."

During the past decade, Oncology and Hematology of South Texas conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology and Hematology of South Texas" #1 collaborator was "Donald E. Morisky" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "MD Anderson Symptom Inventory (MDASI-CML)" with 1 trials as a collaborator, "Molecular MD" with 1 trials as a collaborator and "MultiPharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Oncology and Hematology of South Texas" are "Multiple Myeloma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Adenocarcinoma" (1 trials) and "Adenocystic Carcinoma" (1 trials). Many other conditions were trialed in "Oncology and Hematology of South Texas" in a lesser frequency.

Most popular intervention types in "Oncology and Hematology of South Texas" are "Drug" (4 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biomarker Testing (L)" (1 trials), "Carboplatin Chemotherapy" (1 trials), "Dasatinib" (1 trials), "Dexamethasone 4 mg" (1 trials) and "Folic acid 400 -1000 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology and Hematology of South Texas" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Oncology and Hematology of South Texas". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oncology and Hematology of South Texas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology and Hematology of South Texas, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".